应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NEO NeoGenomics
盘前交易 08-03 07:10:11 EDT
15.29
-0.59
-3.72%
盘前
15.44
+0.15
+0.98%
07:02 EDT
最高
15.90
最低
15.27
成交量
285.96万
今开
15.78
昨收
15.88
日振幅
3.97%
总市值
19.57亿
流通市值
17.89亿
总股本
1.28亿
成交额
4,454万
换手率
2.44%
流通股本
1.17亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
市场消息:NEO电池公司获得韩国大型军用无人机制造商的定制电池订单。
智通财经 · 07-30
市场消息:NEO电池公司获得韩国大型军用无人机制造商的定制电池订单。
NeoGenomics:2026年第二季度运营费用下降,主因2025年同期确认2000万美元减值损失
美股速递 · 07-29
NeoGenomics:2026年第二季度运营费用下降,主因2025年同期确认2000万美元减值损失
财报前瞻|NeoGenomics本季度营收预计增长7.83%,机构观点偏积极
财报Agent · 07-21
财报前瞻|NeoGenomics本季度营收预计增长7.83%,机构观点偏积极
【8点见】西安交大再获匿名捐款,这次是3000万元
央视网 · 07-19
【8点见】西安交大再获匿名捐款,这次是3000万元
NeoGenomics推出FDA批准的前列腺癌伴随诊断试剂
环球市场播报 · 07-09
NeoGenomics推出FDA批准的前列腺癌伴随诊断试剂
据印度国家证券交易所数据显示,NEO APEX股票经纪有限责任合伙企业通过大宗交易,以每股42.42卢比的价格购入韦丹塔
智通财经 · 07-03
据印度国家证券交易所数据显示,NEO APEX股票经纪有限责任合伙企业通过大宗交易,以每股42.42卢比的价格购入韦丹塔
NeoGenomics:部分收益及现金或用于回购至多2500万美元流通普通股
美股速递 · 06-17
NeoGenomics:部分收益及现金或用于回购至多2500万美元流通普通股
NeoGenomics将亮相ASCO年会 展示八项癌症检测新研究
环球市场播报 · 05-26
NeoGenomics将亮相ASCO年会 展示八项癌症检测新研究
中国南方航空股份(01055)购买102架A320 NEO系列飞机
智通财经 · 04-29
中国南方航空股份(01055)购买102架A320 NEO系列飞机
Leerink Partners上调NeoGenomics评级至跑赢大盘 目标价大幅调升至25美元
美股速递 · 04-29
Leerink Partners上调NeoGenomics评级至跑赢大盘 目标价大幅调升至25美元
观察|在“新”与“变”中,经济中心城市如何挑大梁
澎湃新闻 · 04-23
观察|在“新”与“变”中,经济中心城市如何挑大梁
道达尔能源完成英国上游业务合并,成立新公司NEO NEXT+
环球市场播报 · 03-30
道达尔能源完成英国上游业务合并,成立新公司NEO NEXT+
光线传媒12.2亿收购奥林NEO项目,东方资产、翰同资本成功退出
微博财经-财道工作室 · 2025-03-11
光线传媒12.2亿收购奥林NEO项目,东方资产、翰同资本成功退出
《哪咤2》爆火后 光线传媒12.2亿收购北京奥林NEO办公楼
观点网 · 2025-03-10
《哪咤2》爆火后 光线传媒12.2亿收购北京奥林NEO办公楼
券商晨会精华 | NEO Gamma人形机器人发布 新材料应用迎催化
智通财经网 · 2025-02-26
券商晨会精华 | NEO Gamma人形机器人发布 新材料应用迎催化
异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景
异动解读 · 2025-02-20
异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景
Neogenomics, Inc.盘中异动 早盘急速拉升5.12%报13.04美元
市场透视 · 2025-02-20
Neogenomics, Inc.盘中异动 早盘急速拉升5.12%报13.04美元
B of A Securities:维持NeoGenomics(NEO.US)评级,由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。
金融界 · 2025-02-19
B of A Securities:维持NeoGenomics(NEO.US)评级,由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。
加载更多
公司概况
公司名称:
NeoGenomics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Neogenomics, Inc.于1988年10月29日在内华达州注册成立。该公司专门从事癌症遗传学测试和信息服务,为医生提供世界上最全面的以肿瘤为中心的测试菜单之一,帮助他们诊断和治疗癌症。公司的药物服务部为制药客户提供临床试验和药物开发服务。1998年10月29日,母公司作为美国通信企业有限公司在内华达州注册成立,母公司在2001年12月14日更名为Neogenomics, Inc.。
发行价格:
--
{"stockData":{"symbol":"NEO","market":"US","secType":"STK","nameCN":"NeoGenomics","latestPrice":15.29,"timestamp":1785528000000,"preClose":15.88,"halted":0,"volume":2859555,"hourTrading":{"tag":"盘前","latestPrice":15.44,"preClose":15.29,"latestTime":"07:02 EDT","volume":968,"amount":14892.018855999999,"timestamp":1785754935336,"change":0.15,"changeRate":0.00981,"amplitude":0.00981},"delay":0,"changeRate":-0.037153652392947205,"floatShares":117000000,"shares":128000000,"eps":-0.402254,"marketStatus":"盘前交易","change":-0.59,"latestTime":"08-03 07:10:11 EDT","open":15.78,"high":15.9,"low":15.27,"amount":44539004.62161,"amplitude":0.039673,"askPrice":15.48,"askSize":122,"bidPrice":15.29,"bidSize":122,"shortable":3,"etf":0,"ttmEps":-0.402254,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785763800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1355115600000,"exchange":"NASDAQ","adjPreClose":15.29,"preHourTrading":{"tag":"盘前","latestPrice":15.44,"preClose":15.29,"latestTime":"07:02 EDT","volume":968,"amount":14892.018855999999,"timestamp":1785754935336,"change":0.15,"changeRate":0.00981,"amplitude":0.00981},"postHourTrading":{"tag":"盘后","latestPrice":15.5,"preClose":15.29,"latestTime":"19:34 EDT","volume":100491,"amount":1536544.39,"timestamp":1785540847515,"change":0.21,"changeRate":0.013734,"amplitude":0.013734},"volumeRatio":0.7175071488706616,"impliedVol":0.5243,"impliedVolPercentile":0.368},"requestUrl":"/m/hq/s/NEO","defaultTab":"news","newsList":[{"id":"2655705758","title":"市场消息:NEO电池公司获得韩国大型军用无人机制造商的定制电池订单。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655705758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655705758?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:47","pubTimestamp":1785415660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0012050646.USD","WDGF","DRNL","NEO","LU0106261612.USD","ARMY","BK4121","DRNZ","BK4196","FBT","WDRN","JEDI","EUAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107185356","title":"NeoGenomics:2026年第二季度运营费用下降,主因2025年同期确认2000万美元减值损失","url":"https://stock-news.laohu8.com/highlight/detail?id=1107185356","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107185356?lang=zh_cn&edition=full","pubTime":"2026-07-29 04:12","pubTimestamp":1785269529,"startTime":"0","endTime":"0","summary":"NeoGenomics公司指出,2026年第二季度运营费用之所以出现下滑,关键原因在于2025年同期曾计入了高达2000万美元的减值损失。这一对比,显著凸显了费用结构的变化。简单来说,若非这2000万美元的非经常性支出,本季度的运营成本或许会呈现另一番景象。因此,当考察其财务表现时,必须厘清这一特殊项目的影响。这并非营运效率的骤然提升,而是历史基数效应在作祟。投资者在审视这份财报时,应重点关注剔除非经常性损益后的核心运营成本趋势。毕竟,短期内的数字波动,往往掩盖了企业长期发展的真实脉络。真正值得关注的,是公司在剔除这些一次性影响后,其日常经营活动的成本控制能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4196","LU0012050646.USD","BK4121","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126181920","title":"财报前瞻|NeoGenomics本季度营收预计增长7.83%,机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1126181920","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126181920?lang=zh_cn&edition=full","pubTime":"2026-07-21 13:14","pubTimestamp":1784610858,"startTime":"0","endTime":"0","summary":"NeoGenomics将于2026年07月28日发布财报,市场关注营收与盈利弹性以及关键付费方结构变化。一致预期显示,本季度NeoGenomics营收预计为1.97亿美元,同比增长7.83%;调整后每股收益预计为0.03美元,同比增长45.33%;息税前利润预计为-1,902.55万美元,同比增长19.73%。上季度NeoGenomics实现营收1.87亿美元,同比增长11.09%;毛利率43.32%;归属于母公司股东的净利润为-1,710.60万美元,同比改善明显,净利率为-9.16%;调整后每股收益为0.01美元,同比持平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|NeoGenomics本季度营收预计增长7.83%,机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652537142","title":"【8点见】西安交大再获匿名捐款,这次是3000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652537142","media":"央视网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652537142?lang=zh_cn&edition=full","pubTime":"2026-07-19 07:55","pubTimestamp":1784418900,"startTime":"0","endTime":"0","summary":"国家发改委安排3000万元支持重庆山体崩塌灾害灾后应急恢复。据西安交通大学官方公众号18日消息,近日,该校一位匿名校友捐资3000万元,在经济与金融学院设立“梦楦基金”,长期专项支持学生学业发展与科技创新实践工作。2026年是西安交通大学建校130周年暨西迁70周年,近期不少校友向母校捐款。图源:西安交通大学官方公众号四人共同操纵股票获利1.57亿元,被证监会罚没6.27亿元。火箭军某部上等兵汤祥缤以700.9分斩获火箭军女兵第一名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2026-07-19/doc-iniihuvr0451676.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-07-19/doc-iniihuvr0451676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FBT","NEO","BK4121","BK4196","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650241439","title":"NeoGenomics推出FDA批准的前列腺癌伴随诊断试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2650241439","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650241439?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:46","pubTimestamp":1783601160,"startTime":"0","endTime":"0","summary":"NeoGenomics公司宣布推出PTEN IHC CDx检测试剂,这是美国FDA批准的首款用于前列腺腺癌患者的免疫组织化学伴随诊断试剂。TRUQAP近期已获FDA批准上市。 该检测由NeoGenomics旗下全国肿瘤实验室网络的病理学家执行,单独下单时通常在一至两天内出具结果,已获纽约州批准使用。 NeoGenomics医疗服务副总裁Nathan Montgomery表示,治疗侵袭性前列腺癌的临床医生长期需要靶向疗法及配套的筛选工具,此次将PTEN IHC CDx整合入NEO PanTracer Pro,为社区肿瘤诊所提供了经FDA批准的伴随诊断选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihfihu7566436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NEO","BK4196","LU0106261612.USD","LABU","BK4585","LU0012050646.USD","BK4121","FBT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648796669","title":"据印度国家证券交易所数据显示,NEO APEX股票经纪有限责任合伙企业通过大宗交易,以每股42.42卢比的价格购入韦丹塔","url":"https://stock-news.laohu8.com/highlight/detail?id=2648796669","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648796669?lang=zh_cn&edition=full","pubTime":"2026-07-03 21:49","pubTimestamp":1783086593,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4582","LU0012050646.USD","APEX","BK4196","NEO","BK4121","LU0106261612.USD","IAI","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190600181","title":"NeoGenomics:部分收益及现金或用于回购至多2500万美元流通普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1190600181","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190600181?lang=zh_cn&edition=full","pubTime":"2026-06-17 18:03","pubTimestamp":1781690592,"startTime":"0","endTime":"0","summary":"NeoGenomics公司表示,其部分收益及可用现金或将用于回购价值不超过2500万美元的流通普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4196","NEO","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638154592","title":"NeoGenomics将亮相ASCO年会 展示八项癌症检测新研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2638154592","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638154592?lang=zh_cn&edition=full","pubTime":"2026-05-26 23:08","pubTimestamp":1779808080,"startTime":"0","endTime":"0","summary":"领先的癌症诊断解决方案提供商NeoGenomics今日宣布,将在2026年美国临床肿瘤学会年会上展示八项科学摘要,重点呈现公司在微小残留病检测、精准肿瘤学及真实世界证据等领域的最新进展。本次ASCO年会将于5月29日至6月2日在芝加哥举行。 从财务表现来看,NeoGenomics正保持稳健增长。投资者将密切关注本次ASCO年会上相关研究成果的反馈,以及其对NGS业务增长和毛利率改善的潜在推动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-26/doc-inhzfwqk1331967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0012050646.USD","NEO","BK4196","BK4121","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545526","title":"中国南方航空股份(01055)购买102架A320 NEO系列飞机","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545526","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631545526?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:50","pubTimestamp":1777474239,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国南方航空股份(01055)发布公告,于2026年4月29日,本公司与空中客车公司订立飞机收购协议,以自空中客车公司购买102架A320 NEO系列飞机;厦门航空有限公司,即本公司拥有 55%股权的附属公司,与空中客车公司订立飞机收购协议,以自空中客车公司购买 35 架 A320 NEO 系列飞机。董事们认为,诸如粤港澳大湾区发展、京津冀协同发展以及“一带一路”联合建设等重大国家战略,为本集团带来了更广阔的发展机遇。本集团积极把握这些发展机遇,保持运力份额的稳定增长,并优化机队结构。此次收购将通过提升本集团的运力,增强其市场竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1514","BK4196","LU0012050646.USD","BK4121","BK1123","01055","LU0106261612.USD","NEO","BK1561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183178879","title":"Leerink Partners上调NeoGenomics评级至跑赢大盘 目标价大幅调升至25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183178879","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183178879?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:33","pubTimestamp":1777462396,"startTime":"0","endTime":"0","summary":"投资机构Leerink Partners宣布将癌症检测公司NeoGenomics的股票评级从\"与大市持平\"上调至\"跑赢大盘\",同时将其目标股价从12美元大幅提升至25美元,显示出对该公司在肿瘤基因检测领域发展前景的强烈信心。\n此次评级调整反映了分析师对NeoGenomics业务转型和增长潜力的重新评估。目标价的大幅上调表明Leerink Partners认为该公司当前股价尚未充分反映其未来价值,预计其股价将有显著上行空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","LU0012050646.USD","BK4121","BK4196","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629829005","title":"观察|在“新”与“变”中,经济中心城市如何挑大梁","url":"https://stock-news.laohu8.com/highlight/detail?id=2629829005","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629829005?lang=zh_cn&edition=full","pubTime":"2026-04-23 11:12","pubTimestamp":1776913948,"startTime":"0","endTime":"0","summary":"澎湃新闻记者邹娟见习记者洪旭东“十五五”开局,上海经济运行起势有力、向上向好。4月22日,上海公布一季度经济数据:全市生产总值达到13526.91亿元,同比增长5.9%,高于全国0.9个百分点,实现“开门红”,在全国发展大局中发挥了经济中心城市挑大梁作用。重点行业实现均衡增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604233715723314.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233715723314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4121","LU0012050646.USD","BK4196","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623348893","title":"道达尔能源完成英国上游业务合并,成立新公司NEO NEXT+","url":"https://stock-news.laohu8.com/highlight/detail?id=2623348893","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623348893?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:43","pubTimestamp":1774874580,"startTime":"0","endTime":"0","summary":"道达尔能源已完成其英国上游油气业务与NEO NEXT的合并,成立了一家名为NEO NEXT+的新公司,并在合并后的实体中持有47.5%的股份。 该交易使NEO NEXT+成为英国大陆架上最大的独立油气生产商,预计2026年的日产量将超过25万桶油当量。 根据此前披露的条款,在所有权结构方面,道达尔能源持有NEO NEXT+ 47.5%的股份,HitecVision持有28.875%,雷普索尔持有23.625%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-30/doc-inhsuquq3875012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4121","LU0012050646.USD","LU2129689431.USD","LU2237443382.USD","LU2237443622.USD","LU2237443549.SGD","BK4588","LU2129689514.USD","LU2129689605.HKD","LU2237443978.SGD","TTE","159945","NEO","BK4144","LU2237443895.HKD","LU0106261612.USD","LU2237443465.HKD","BK4201","BK4196","NEXT","BK4561","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518439713","title":"光线传媒12.2亿收购奥林NEO项目,东方资产、翰同资本成功退出","url":"https://stock-news.laohu8.com/highlight/detail?id=2518439713","media":"微博财经-财道工作室","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518439713?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:38","pubTimestamp":1741682280,"startTime":"0","endTime":"0","summary":"光线传媒近日公告计划斥资12.2亿元收购北京奥林NEO办公楼,交易对手为东方资产、翰同资本等。尽管当前办公楼市场面临一定空置率压力,但光线传媒对奥林NEO项目的升值空间仍表达了乐观态度。本次出售奥林NEO有助于东方资产进一步改善资产流动性,加快投资收益落袋。今年2月,东方资产公告控股股东变更为中央汇金公司。此次光线传媒承债式收购奥林NEO,意味着大连银行的信贷资金将得到保证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-03-11/doc-inephnhf9666802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0087","BK0049","BK0188","BK0267","BK0108","BK4121","LU0012050646.USD","BK0083","BK4196","BK0200","BK0098","LU0106261612.USD","NEO","300251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518879284","title":"《哪咤2》爆火后 光线传媒12.2亿收购北京奥林NEO办公楼","url":"https://stock-news.laohu8.com/highlight/detail?id=2518879284","media":"观点网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518879284?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:25","pubTimestamp":1741537512,"startTime":"0","endTime":"0","summary":"3月7日晚,光线传媒发布购买资产公告,宣布将斥资12.2亿元购买北京棫霖企业管理有限公司100%股权,从而取得位于北京市朝阳区的北京奥林NEO大楼作为办公场所。根据公司2024年三季报显示,光线传媒期内营业收入仅有14.42亿元,归母净利润为4.61亿元,扣非归母净利润为4.33亿元。也就是说,光线传媒实质上是买下了北京奥林NEO这座办公楼。根据公司披露的交易公告,光线传媒此次收购奥林NEO项目所涉及的全部款项合计人民币12.20亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10002548615300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0087","BK0049","LU0012050646.USD","NEO","BK0188","BK0108","BK4121","BK0083","BK0200","BK4196","BK0098","LU0106261612.USD","300251","BK0267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514029642","title":"券商晨会精华 | NEO Gamma人形机器人发布 新材料应用迎催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029642","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514029642?lang=zh_cn&edition=full","pubTime":"2025-02-26 08:24","pubTimestamp":1740529470,"startTime":"0","endTime":"0","summary":"银河证券表示,机场板块层面,当前机场板块对于免税协议重签扣点率下降的悲观情绪基本已被priced in。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4196","159703","NEO","BK4121","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121407072","title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1121407072","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121407072?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:24","pubTimestamp":1739982268,"startTime":"0","endTime":"0","summary":"NeoGenomics(NEO)公司今日盘中股价大涨5.20%,引发市场关注。\n分析人士指出,这很可能与华尔街分析师看好该公司前景有关。路透社报道,杰富瑞(JEF)分析师将NeoGenomics的目标价从22美元下调至18美元,反映出分析师仍然对该公司持相对乐观态度。\nNeoGenomics是一家癌症诊断和生物疗法公司,行业前景广阔。虽然面临诸多不确定性,但有分析师维持中性评级并上调目标价,表明公司业务仍备受看好。投资者对NeoGenomics长期增长前景持乐观态度,推动其盘中大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512848814","title":"Neogenomics, Inc.盘中异动 早盘急速拉升5.12%报13.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848814?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:22","pubTimestamp":1739982152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时22分,Neogenomics, Inc.股票出现波动,股价大幅拉升5.12%。截至发稿,该股报13.04美元/股,成交量55.049万股,换手率0.43%,振幅9.83%。Neogenomics, Inc.股票所在的生命科学行业中,整体涨幅为0.87%。Neogenomics, Inc.公司简介:NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络,并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","NEO","BK4121","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512102631","title":"B of A Securities:维持NeoGenomics(NEO.US)评级,由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512102631","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512102631?lang=zh_cn&edition=full","pubTime":"2025-02-19 21:21","pubTimestamp":1739971312,"startTime":"0","endTime":"0","summary":"B of A Securities:维持NeoGenomics(NEO.US)评级,由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19212148266507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neogenomics.com","stockEarnings":[{"period":"1week","weight":0.1008},{"period":"1month","weight":0.0214},{"period":"3month","weight":0.6197},{"period":"6month","weight":0.2678},{"period":"1year","weight":2.1591},{"period":"ytd","weight":0.3002}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neogenomics, Inc.于1988年10月29日在内华达州注册成立。该公司专门从事癌症遗传学测试和信息服务,为医生提供世界上最全面的以肿瘤为中心的测试菜单之一,帮助他们诊断和治疗癌症。公司的药物服务部为制药客户提供临床试验和药物开发服务。1998年10月29日,母公司作为美国通信企业有限公司在内华达州注册成立,母公司在2001年12月14日更名为Neogenomics, Inc.。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.004357},{"month":2,"riseRate":0.5,"avgChangeRate":0.012062},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.038488},{"month":4,"riseRate":0.357143,"avgChangeRate":-0.024148},{"month":5,"riseRate":0.642857,"avgChangeRate":0.046304},{"month":6,"riseRate":0.714286,"avgChangeRate":0.064446},{"month":7,"riseRate":0.857143,"avgChangeRate":0.09173},{"month":8,"riseRate":0.461538,"avgChangeRate":0.036189},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.023669},{"month":10,"riseRate":0.615385,"avgChangeRate":0.070403},{"month":11,"riseRate":0.692308,"avgChangeRate":0.100243},{"month":12,"riseRate":0.230769,"avgChangeRate":-0.03319}],"exchange":"NASDAQ","name":"NeoGenomics","nameEN":"NeoGenomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeoGenomics,NEO,NeoGenomics股票,NeoGenomics股票老虎,NeoGenomics股票老虎国际,NeoGenomics行情,NeoGenomics股票行情,NeoGenomics股价,NeoGenomics股市,NeoGenomics股票价格,NeoGenomics股票交易,NeoGenomics股票购买,NeoGenomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}